The solution comes equipped with a Krios G4 Cryo transmission electron microscope, a Falcon 4 camera, and an EPU quality monitor with data management powered by Athena.
The Krios solution from Thermo Fisher Scientific is a solution capable of eliminating the barriers behind cryogenic electron microscopy (cryo-EM) adoption through ease-of-use, faster results, and a compact 300-kV cryo-EM microscope design.
The solution is equipped with a Krios G4 Cryo transmission electron microscope that can fit into a standard-sized lab, a Falcon 4 camera that captures images up to 10 times faster than the previous model, and an EPU quality monitor with data management powered by Athena for researchers working remotely to monitor the quality of the data as it is being collected.
"With the rapid adoption of cryo-EM, it's critical that researchers have fast, accessible solutions that produce the highest-quality results, especially as advanced techniques such as single particle analysis and cryo-tomography grow in importance," said Mike Shafer, president of materials and structural analysis at Thermo Fisher Scientific, in an Aug. 5, 2019 press release. "Our new Krios solution addresses these needs, accelerating scientific discoveries that are helping to solve some of humankind's most pressing problems."
Source: Thermo Fisher Scientific
Why is the PDA Pharmaceutical Microbiology Conference the Hottest Ticket in the Industry?
October 10th 2024Get a glimpse of the power and popularity behind the PDA Pharmaceutical Microbiology Conference from two planning committee members, Julia Marre, PhD (Associate Director, Scientific and Regulatory Affairs at Pocket Naloxone Corp) and Dawn Watson (Executive Director, Global Micro Quality and Sterility Assurance at Merck). This candid conversation reveals why this industry event is so influential…and always sold out! The speakers discuss what makes the PDA Pharmaceutical Microbiology Conference so vital to industry professionals, as well as how to become a part of this dynamic professional community.
Navigating Annex 1 for Early Phase Sterile Fill Finish in Clinical Supplies
November 21st 2024Stay compliant with Annex 1 for early phase sterile fill finish processes. Discover how to implement robust contamination control strategies, integrate isolator technology, and conduct integrity testing to meet stringent European Union standards. The guide provides a comprehensive look at key elements such as PUPSIT, critical zone controls, and monitoring and training for aseptic processes.
Your Ultimate Guide for CMC Testing Support for Gene and Cell Therapy
November 21st 2024Explore the complexities of gene and cell therapy development with our comprehensive guide to Chemistry, Manufacturing, and Controls (CMC) testing. Learn how our expertise ensures the safety, potency, and quality of advanced therapies, supporting your journey from product development through regulatory approval.